Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings. - Wikidata - wikimedia - TriplyDB

Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.

Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.

http://www.wikidata.org/entity/Q35064955

about

Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle properties Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer Nanoways to overcome docetaxel resistance in prostate cancer.Future of the particle replication in nonwetting templates (PRINT) technology PRINT: a novel platform toward shape and size specific nanoparticle theranostics.Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft.Rapidly-dissolvable microneedle patches via a highly scalable and reproducible soft lithography approach.Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.More effective nanomedicines through particle design Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle.Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery.Scalable imprinting of shape-specific polymeric nanocarriers using a release layer of switchable water solubility Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing.Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer Effect of aspect ratio and deformability on nanoparticle extravasation through nanopores.Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation.Engineering nanomedicines using stimuli-responsive biomaterials.Nanomedicine in chemoradiation.Generating Better Medicines for Cancer.Controlled release behaviour of protein-loaded microparticles prepared via coaxial or emulsion electrospray.Advances in drug delivery via electrospun and electrosprayed nanomaterials Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy RNA replicon delivery via lipid-complexed PRINT protein particles.Docetaxel nanotechnology in anticancer therapy.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Emerging applications of phase-change materials (PCMs): teaching an old dog new tricks.Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications.Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.Materials and methods for delivery of biological drugs.From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers.Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases.PLGA: the smart therapeutics goods carrier.Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications.Cell membrane coated nanoparticles: next-generation therapeutics.“Smart” Surface Capsules for Delivery Devices Elaborate Design Strategies Toward Novel Microcarriers for Controlled Encapsulation and Release Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype

P2860

Q27493140-5723DD49-8EEF-41D5-858B-85F9D51AE12A Q30744724-FA0193D0-836B-4941-A9B7-31DFFFCF9821 Q33875597-6CF181FC-E007-4AD3-B8BC-07F82EF7293B Q33909084-7AD67E0B-FBA2-4B23-87BE-DDC1F3798BFB Q34149094-FB057E23-0465-4BE1-954B-2C9BB3EDF203 Q34149121-CF7962B0-FBE2-4A4F-BE41-F23BCC84D35E Q34316088-74DBF810-8A37-4E3B-8816-1C576A154CE7 Q34671534-C3E7E4DC-3A17-404D-82C7-D6EAE9064BE3 Q34675068-09AAAEE3-7B28-4FB9-9BA6-9F1F9AAC4D2A Q35106115-AFE8E93A-7F74-437A-AE1F-5893C98F1CDA Q35551143-1AE30E4C-951A-41B5-B1F2-429FFA7BAA18 Q35801327-D8CEF392-07F2-49D6-B7FE-C65BBEB9DD58 Q35856885-2BED98BE-C056-4686-8278-940F0F62CB15 Q35975665-ABD5546A-BCEE-4A73-B897-429574671345 Q35982462-F12D33D5-954A-4319-9DCE-6D3F5E40DD64 Q36028372-E120911E-C1B9-443E-85A8-9537C4758DDF Q36132897-031A01F8-C5E7-4B96-AE6E-72CAD245E4AD Q36174884-EA54F445-062B-45F9-A60A-2FDB59DF7025 Q36838995-A841563B-AC04-431A-B5CA-94AB91589FBA Q36922604-B1D55CA4-A8EC-4180-B1C6-15FAE5F2BC9E Q37007729-9889B9EF-8C51-486C-89A9-E8DF2D3EC9C9 Q37103471-69B0C6E8-9E1D-4878-AA2A-B73E83D1CA09 Q37253857-3DDBE39F-5AB5-4773-9D70-C3F054F74F2F Q37628162-23E3035B-CA90-4A25-9A63-0186FBC4D76B Q38003964-3F847A58-2861-423B-9D7B-CD6124EDCB19 Q38150118-7574A6D6-75CA-4988-A3A9-BD967124DC51 Q38182510-593A4949-BF5E-4695-8AE0-91CEB9000085 Q38261278-6C08123F-003A-4E1C-AFAF-F781DC812E32 Q38865261-B69F7BDE-51F2-418C-9817-31838BD71279 Q38987392-AAF4EEDC-180E-4916-A546-F275FE502DA3 Q39060269-8D78AAE7-B7B7-43E9-AA43-0E2BEECB21FF Q39325848-9FD4567E-136E-4C75-BBCD-DABD81CF9838 Q41280444-CF9B9F8B-8278-41A9-A860-CA46BDE29CC5 Q41545490-2616B793-BCF4-4AF5-9659-B5CB631F383B Q42237070-0C216FA6-F0BD-465C-B4AF-C41C4F6DF2CD Q47613637-EC5B092B-C94F-4F20-9B3E-A2EC7F02E750 Q57341622-07DD41A2-366B-46A1-929F-D45E85F9216C Q58344054-92E74462-FF1D-4E78-9CBD-956A5A52F14B Q58699988-0EC1D968-C3C3-4D64-A852-B12BD8662796

P2860

Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.

http://www.wikidata.org/entity/Q35064955

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.

@ast

Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.

@en

type

label

Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.

@ast

Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.

@en

prefLabel

Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.

@ast

Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.

@en

P1433

Q35064955-49B48154-C676-458F-9469-5BB0205D5A58

P1476

Q35064955-42864F00-D9D9-4CDD-8987-DA8162C38605

P2093

Q35064955-1BEA9C76-1958-42C7-B47D-AA605892A91A

Q35064955-2220F1CC-0832-4498-957B-7F7CCBEDE65F

Q35064955-51ED29CA-9694-4967-AA7C-29C6D99CC9C4

Q35064955-52B61C63-20B5-4878-8993-2A7967A8C1F1

P2860

Q35064955-0DB5923E-C6B2-4450-85C5-578FFD40BFDE

Q35064955-1277AE9B-B468-4256-899A-1C526FD617BA

Q35064955-230C3E82-F10A-4159-88B3-6BC82ABE6F40

Q35064955-24E7141E-B956-4469-8C29-DBAEBE98C173

Q35064955-2A1B1617-2AAE-44A6-B7CD-08600427097B

Q35064955-30350AC7-0C14-4125-9C80-2BD86B5860AA

Q35064955-35A7544A-B4A1-4691-B83C-A769CC209DA7

Q35064955-3A597FFA-C438-4271-8F46-FE2689D66463

Q35064955-42E98BBB-AA9C-4503-A28D-0A50FF95C7BF

Q35064955-5D75C6D0-BD95-4F2E-A856-647E2BABC86B

P304

Q35064955-C324421D-C5C0-4F8C-BC05-D920300EEFC6

P31

Q35064955-864A5B5D-5F8B-4CD6-B324-7BAA573E98EC

P356

Q35064955-3EC2CCCD-44E1-4F67-A3E0-A165C476168B

P407

Q35064955-9C25F8D5-A2F4-4024-9BA9-08A6E0064DD3

P433

Q35064955-7633DC1C-E9F5-4FBA-A922-0F5D1B568708

P478

Q35064955-C157BB2E-36E9-4DAF-A46C-12D525521533

P577

Q35064955-B1CEE1A7-ED69-4B64-A2A2-1D0E09A77B1A

P5875

Q35064955-2862C369-9F62-49DF-A796-3427BB64C39B

P698

Q35064955-38CAB618-17D3-48D9-81B4-B33B84B2C35E

P921

Q35064955-0D190E3B-B73C-4A60-AB10-6C0059B1C5CB

Q35064955-25EDD41E-282B-4C3C-8C6C-C1D88CB8E70D

P932

Q35064955-2A182BDA-2A69-4023-8C18-BD4C35DA9820

P356

P1433

P1476

Potent engineered PLGA nanopar ...... igh chemotherapeutic loadings.

@en

P2093

Elizabeth M Enlow

http://www.w3.org/2001/XMLSchema#string

J Christopher Luft

http://www.w3.org/2001/XMLSchema#string

Joseph M DeSimone

http://www.w3.org/2001/XMLSchema#string

Mary E Napier

http://www.w3.org/2001/XMLSchema#string

P2860

Role of target geometry in phagocytosis.

Comparative study of DNA encapsulation into PLGA microparticles using modified double emulsion methods and spray drying techniques.

Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.

Scalable, shape-specific, top-down fabrication methods for the synthesis of engineered colloidal particles

Docetaxel: a review of its use in metastatic breast cancer.

Imparting size, shape, and composition control of materials for nanomedicine.

Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers.

The effect of particle design on cellular internalization pathways.

Nanoparticles for drug delivery in cancer treatment.

Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage

P304

808-813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NL104117P

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49784108

http://www.w3.org/2001/XMLSchema#string

P698

21265552

http://www.w3.org/2001/XMLSchema#string

P921

P932

3122105

http://www.w3.org/2001/XMLSchema#string